Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Acute Lymphoblastic Leukemia
93%
Overall Survival
67%
Lymphoma
52%
Chemotherapy
44%
Adult Patients
43%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
42%
Complete Remission
39%
Leukemia Patients
36%
AIDS/HIV
34%
Non-Hodgkin Lymphoma
32%
Blinatumomab
32%
Confidence Interval
30%
Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
28%
Minimal Residual Disease
28%
Diffuse Large B-cell Lymphoma (DLBCL)
27%
Acute Myeloid Leukemia
27%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
25%
Bone Marrow
23%
Relapsed or Refractory
22%
BCP-ALL
22%
Older Adults
22%
Human Immunodeficiency Virus Infection
18%
Stem Cell Transplantation
18%
Prognostic Factors
18%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
17%
Burkitt Lymphoma
17%
Prognostic Significance
17%
Hematological Malignancies
16%
Intensive Chemotherapy
16%
Leukemia
16%
High Risk
16%
Follicular Lymphoma
16%
Hematopoietic Stem Cell Transplantation
15%
Highly Active Antiretroviral Therapy (HAART)
15%
Working Diagnosis
15%
Leukemia-free Survival
15%
Lymphoma Patients
14%
Patients with Hematological Malignancies
14%
Adult Acute Lymphoblastic Leukemia
14%
Multivariate Analysis
13%
Response to Treatment
13%
Flow Cytometry
13%
Intensive Care Unit
13%
Acute Leukemia
13%
Imatinib
12%
HIV Patients
12%
Acute Promyelocytic Leukemia
12%
Immunochemotherapy
12%
Prognostic Impact
12%
Prognostic Score
12%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Overall Survival
55%
Human Immunodeficiency Virus
45%
Leukemia
33%
Non-Hodgkin Lymphoma
30%
Philadelphia 1 Chromosome
29%
Diffuse Large B-Cell Lymphoma
27%
Hematologic Malignancy
25%
Blinatumomab
25%
B Cell
25%
Acute Myeloid Leukemia
22%
Human Immunodeficiency Virus Infection
21%
Diseases
19%
Prognostic Factor
18%
Pediatrics
18%
Cumulative Incidence
17%
Precursor
17%
Burkitt's Lymphoma
17%
Neoplasm
16%
Follicular Lymphoma
15%
Central Nervous System
14%
Minimal Residual Disease
14%
Acute B-Cell Lymphoblastic Leukemia
14%
Allogeneic Hematopoietic Stem Cell Transplantation
13%
Acute Leukemia
13%
Flow Cytometry
13%
Intensive Care Unit
13%
Multivariate Analysis
13%
Survival Rate
13%
Radiation Therapy
12%
Highly Active Antiretroviral Therapy
12%
Leukocyte
11%
Rituximab
10%
Stem Cell Therapy
10%
Progression Free Survival
10%
Multiple Myeloma
10%
Drug Megadose
10%
Spontaneous Remission
10%
Elderly Patient
9%
Acute Promyelocytic Leukemia
9%
Hematopoietic Stem Cell Transplantation
9%
Allogeneic Stem Cell Transplantation
9%
Antiretroviral Therapy
9%
Anthracycline
9%
De Novo Acute Myeloid Leukemia
9%
T Cell
9%
Cytarabine
9%
Hazard Ratio
8%
Disease Free Survival
8%
Lymphocyte
8%
